| Serial Number | 79437594 |
| Word Mark | STRIMVELIS |
| Filing Date | Friday, August 8, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, July 20, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations for gene therapy for the treatment of severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID); medicine, namely, autologous 34+ cells transduced to express ADA; pharmaceutical preparations for treating ADA-SCID |
| Goods and Services | Biological research, clinical research in the field of gene therapy and medical research; medical research laboratory services; research and development of vaccines and medicines; scientific research services in the preparation of biological samples f o r testing and analysis in research laboratories; genetic scientific research; scientific research and development; pharmaceutical drug development services; providing information on clinical studies via an interactive website; medical and scientific research, namely, conducting clinical trials for others; DNA screening for scientific research purposes; design and development of computer hardware and software; research and development of new products for others; conducting technical scientific feasibility project studies; rental of computer software for collecting, analysing and organizing data in the field of medical research and treatment of genetic diseases; computer programming; conversion of computer programs and data, other than physical conversion; recovery of computer data; quality control for others; material testing; engineering, namely, surveying; conversion of data or documents from physical to electronic media; bacteriological research; hosting of communication computer platforms on the internet; programming of software for Internet platforms; pharmaceutical products development; scientific research services; scientific laboratory services; structural and functional analysis of genomes; development of pharmaceutical preparations and medicines; scientific research consultancy in relation to assessments, estimates, and researches in science and technology rendered by engineers; providing information in the nature of evaluations and estimations in the field of medical research; industrial research and biological analysis in the field of health; providing of imaging and physiology platforms, namely, providing temporary use of online non-downloadable software for analysing medical imaging; research and development of pharmaceuticals and veterinary and hygiene preparations for others; product development and testing of pharmaceuticals in the validation of biological tests, cellular tests, genetic tests and immunological tests of others; gene therapy research and scientific research counselling, in relation to the following fields: research services and therapy |
| Goods and Services | Medical services; medical screening; medical assistance; medical counselling; providing news and information in the field of medicine; performing diagnosis of diseases; medical advisory services relating to degenerative diseases; medical surgical diagnostic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic services; human hygiene and beauty care; health counselling; hospital services; nursing home services; pharmacy advice, namely, prescription management and reviews; medical imaging services; human tissue bank services; conducting of medical examinations; medical consultations; medical and health care services relating to DNA, genetics and genetic testing; telemedicine services; stem cell therapy services; preparation and dispensing of medications; providing of medical information in the pharmaceutical field; medical, alternative medicinal and pharmaceutical consultancy |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 27, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 27, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 27, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | FONDAZIONE TELETHON ETS |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | IT |
| Event Date | Event Description |
| Thursday, November 27, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, December 4, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 4, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, December 22, 2025 | ASSIGNED TO EXAMINER |
| Monday, December 22, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 23, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, January 26, 2026 | REFUSAL PROCESSED BY MPU |
| Monday, January 26, 2026 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, February 12, 2026 | REFUSAL PROCESSED BY IB |
| Monday, July 20, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 20, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 20, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |